WHO moves step closer to cheaper breast cancer treatment
The World Health Organization (WHO) announced Wednesday that it had for the first time approved a “biosimilar” medicine—one derived from
Read more
The World Health Organization (WHO) announced Wednesday that it had for the first time approved a “biosimilar” medicine—one derived from
Read moreWhether you’re traveling for work or for fun, nothing ruins the start of a trip quite like jet lag. Engineers
Read morePeople exposed to higher levels of air pollution are more likely to experience depression or die by suicide, finds a
Read moreHow can the perspectives of patients with multiple sclerosis (MS) be given more consideration in clinical trials? This question was
Read moreMedicines such as insulin for diabetes and clotting factors for hemophilia are hard to synthesize in the lab. Such drugs
Read moreDense Breast Notifications (DBNs) are having little impact. DBNs are a written notification to a woman after a mammogram that
Read moreA sophisticated type of artificial intelligence (AI) can outperform existing models at predicting which women are at future risk of
Read moreLung cancer is the leading cause of cancer death in the United States and approximately 75-80 percent of all cases
Read moreAn experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma
Read moreMost people experience anxiety and stress, pain, and even insomnia due to our hectic schedules in work and personal life.
Read more